Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan (Q24328949)
scientific article
Language:
Current Data About Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
(P31) (Q13442814)

(P304) 7082-7

(P407) (Q1860)

(P433) 15

(P478) 67

(P577) Wednesday, August 1, 2007

(P921) (Q7094)

(Q21172579)
(P248)

(Q14907409)
(P248)

(Q14907419)
(P248)

(Q21498600)
(P248)

(P1433) (Q326097)

(P1476) "Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan" (language: en)

(P2093) Richard Metz
(P1545) 1

James B Duhadaway
(P1545) 2

Uma Kamasani
(P1545) 3

Lisa Laury-Kleintop
(P1545) 4

Alexander J Muller
(P1545) 5

George C Prendergast
(P1545) 6

(P2860) (Q29614752)
(P248)
(P813) Friday, May 31, 2024
(P854) https://opencitations.net/index/api/v1/citations/10.1038/NRI1457

(Q24336018)
(P248)
(P813) Friday, May 31, 2024
(P854) https://opencitations.net/index/api/v1/citations/10.1126/SCIENCE.281.5380.1191